IMS Health’s Nexxus Mobile Intelligence CRM Powers VAYA Pharma’s Commercial Operations
February 17 2016 - 8:15AM
Business Wire
Life Sciences Cloud Solution Unifies,
Automates Customer Engagement
IMS Health (NYSE:IMS) today announced that VAYA Pharma, a
specialty medical food division of Enzymotec Ltd. (NASDAQ:ENZY),
has adopted IMS Health's Nexxus™ Mobile Intelligence CRM solution
to support the successful expansion of VAYA's sales team and
commercial operations. Designed for the life sciences market, this
mobile field solution seamlessly integrates IMS Health, industry
data and VAYA intelligence with decision-support tools to fuel more
coordinated and productive customer engagements.
VAYA Pharma develops, manufactures and markets innovative
lipid-based treatments to address health conditions associated with
nutritional imbalances. VAYA Pharma’s current medical food
portfolio addresses three therapeutic segments: ADHD with Vayarin®,
Early Memory Impairment with Vayacog® and Hypertriglyceridemia with
Vayarol®.
“This is an exciting time for VAYA and it’s essential we have
the appropriate technology in place in order to successfully
execute our commercial growth strategy,” said Rob Crim, CEO, VAYA
Pharma. “We selected IMS Health as a partner because of its deep
pharma and healthcare expertise, and its business-enabled
technology solutions are purpose-built for the life sciences.”
By curating insights, Nexxus MI helps commercial teams tailor
precision conversations across customers’ preferred communications
channels. The mobile-optimized solution empowers field teams to
interact with healthcare professionals on any digital device.
Nexxus MI makes it fast and simple for sales representatives to
capture details of customer interactions directly from their
tablets in the field. In addition, most Nexxus MI functions are
available offline, which is beneficial to customer-facing
professionals who often work in locations where connectivity may
not be available.
Nexxus MI’s highly intuitive interface and usability were key
factors in VAYA’s decision to partner with IMS Health. Compared to
the prior CRM system, Nexxus MI has achieved higher utilization
rates among VAYA’s sales representatives. The IMS Health cloud
solution also benefits VAYA’s home office by offering robust
account management capabilities while significantly reducing
administration and maintenance requirements.
“We’re very pleased to support VAYA as it expands its commercial
operations to reflect the continued increased adoption of the
company's products by healthcare providers and their patients,”
said Tal Rosenberg, general manager, Technology Solutions, IMS
Health. “With Nexxus MI, VAYA’s sales force has the pertinent tools
and insight it needs to deliver the right messages to the right
healthcare providers at the right time, which is critical for the
advancement of patient care and health outcomes.”
Nexxus MI is part of the Nexxus Commercial Application Suite,
which brings together the most complete and fully connected set of
applications across the commercial continuum, from marketing
campaign management and social media monitoring to customer
engagement, sales operations and performance management. For more
information, visit www.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
end-to-end solutions to measure and improve their performance. Our
7,500 services experts connect configurable SaaS applications to
10+ petabytes of complex healthcare data in the IMS One™ cloud
platform, delivering unique insights into diseases, treatments,
costs and outcomes. The company’s 15,000 employees blend global
consistency and local market knowledge across 100 countries to help
clients run their operations more efficiently. Customers include
pharmaceutical, consumer health and medical device manufacturers
and distributors, providers, payers, government agencies,
policymakers, researchers and the financial community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160217005299/en/
IMS Health Media RelationsTor Constantino,
+1.484.567.6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024